NPAS3-IN-1
CAS No. 2207-44-5
NPAS3-IN-1( —— )
Catalog No. M37303 CAS No. 2207-44-5
NPAS3-IN-1 is a potent inhibitor of NPAS3-ARNT heterodimerization, modulating NPAS3 transcription by targeting the interaction between NPAS3 and ARNT at the cellular level.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 116 | Get Quote |
|
| 5MG | 179 | Get Quote |
|
| 10MG | 282 | Get Quote |
|
| 25MG | 477 | Get Quote |
|
| 50MG | 679 | Get Quote |
|
| 100MG | 888 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameNPAS3-IN-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionNPAS3-IN-1 is a potent inhibitor of NPAS3-ARNT heterodimerization, modulating NPAS3 transcription by targeting the interaction between NPAS3 and ARNT at the cellular level.
-
DescriptionNPAS3-IN-1 is a potent inhibitor of NPAS3-ARNT heterodimerization and regulates NPAS3 transcription by disrupting the heterodimerization of NPAS3 with ARNT at the cellular level.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2207-44-5
-
Formula Weight295.36
-
Molecular FormulaC10H5N3O2S3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 25 mg/mL (84.64 mM; Ultrasonic )
-
SMILESO=[N+]([O-])C1=CN=C(SC2=NC3=C(S2)C=CC=C3)S1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Li P, et al. Discovery of a highly potent NPAS3 heterodimer inhibitor by covalently modifying ARNT. Bioorg Chem. 2023 Oct;139:106676.?
molnova catalog
related products
-
Isophorone
Isophorone (355-trimethyl-2-cyclohexen-1-one) a monoterpene and the structurally related 18-cineole and camphor have demonstrated a protective effect against cancer biological activity against a variety of microorganisms and anti-oxidant properties.
-
NMDAR antagonist 1
NMDAR antagonist 1 is a potent and orally bioavailable NR2B-selective antagonist of NMDAR.
-
Nemorubicin
Nemorubicin is a doxorubicin derivative that differs significantly from its parent drug in terms of spectrum of antitumor activity, metabolism and toxicity profile.?
Cart
sales@molnova.com